1-2 of 2
Tzipi Lustig
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Use of Combination Premedication Prior to Motixafortide Administration Reduced Severity and Frequency of AEs in the Phase 3 Genesis Trial - a Single Center Analysis

Zachary David Crees, Keith Stockerl-Goldstein, Mark A. Schroeder, Ravi Vij, Ella Sorani, Irit Gliko Kabir, Inbal Goldstein, Tzipi Lustig, Shaul Kadosh, John F. DiPersio
Journal: Blood
Blood (2023) 142 (Supplement 1): 3522.
https://doi.org/10.1182/blood-2023-181452
Published: 2023
Journal Articles

The Selective Anti Leukemic Effect of BL-8040, a Peptidic CXCR4 Antagonist, Is Mediated By Induction of Leukemic Blast Mobilization, Differentiation and Apoptosis: Results of Correlative Studies from a Ph2a Trial in Acute Myeloid Leukemia

Gautam Borthakur, MD, Martin S. Tallman, MD, Yishai Ofran, MD, James M. Foran, MD, Geoffrey L Uy, MD, John F DiPersio, MD PhD, Arnon Nagler, Jacob M. Rowe, MD, Margaret M. Showel, MD, Jessica Altman, MD, Ahmed Al-Rawi, Rui-Yu Wang, MD PhD, Amnon Peled, PhD, Michal Abraham, PhD, Yaron Pereg, PhD, Abi Vainstein, MD, Galia Oberkovitz, PhD, Tzipi Lustig, DVM, Arnon Aharon, MD, Carlos E. Bueso-Ramos, MD PhD, Jorge E. Cortes, MD, Michael Andreeff, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2745.
https://doi.org/10.1182/blood.V128.22.2745.2745
Published: 2016